Periodontal Treatment Market Outlook 2031 Sees Growth to Over US$ 12.2 Billion by 2031, with a 4.8% CAGR from 2022

The Periodontal Treatment Market is poised for significant growth driven by rising awareness about oral health, advancements in treatment modalities, and increasing prevalence of periodontal diseases worldwide. With the global industry valued at US$ 7.6 billion in 2021, the market is projected to expand at a steady CAGR of 4.8% from 2022 to 2031, reaching a valuation exceeding US$ 12.2 billion by 2031.

Market Overview

Periodontal treatment encompasses a range of interventions aimed at managing and preventing periodontal diseases, including gingivitis and periodontitis. It involves both non-surgical and surgical approaches to address gum inflammation, tissue damage, and bone loss associated with these conditions.

Request Sample Copy of Market Research Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85283&utm_source=OpenPR_Sandeep&utm_medium=OpenPR

Market Segmentation

The Periodontal Treatment Market is segmented based on various factors:

Treatment Type: Including non-surgical treatment such as scaling and root planning, antibiotics (systemic and local), and surgical treatment such as pocket reduction surgery, soft tissue grafts, and bone grafts.
End-user: Encompassing hospitals, dental clinics, and other healthcare facilities where periodontal treatment services are provided to patients.
Regions Covered: Spanning North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa, reflecting the global distribution of periodontal disease burden and treatment demand.

Key Developments

Several key developments are shaping the landscape of the periodontal treatment market:

Biocomposites partnering with Zimmer Biomet to distribute genex Bone Graft Substitute in the orthopedic market, expanding the availability of regenerative bone products for dental and orthopedic applications.
Envista Holdings Corporation renewing its partnership with the Vitaldent Group, ensuring continued access to dental implants and clear aligners for patients seeking comprehensive oral care.
Amyndas Pharmaceuticals announcing positive phase 2 results for AMY-101 in patients with periodontitis and gingivitis, highlighting the potential of innovative therapies to address unmet needs in periodontal disease management.

Request TOC of Research Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=85283&utm_source=OpenPR_Sandeep&utm_medium=OpenPR

Top of Form

Market Drivers and Challenges

The growth of the periodontal treatment market is driven by various factors:

Increasing prevalence of periodontal diseases globally, fueled by factors such as poor oral hygiene, tobacco use, and aging populations.
Growing awareness about the importance of oral health and preventive dental care, leading to greater demand for periodontal treatment services.
Technological advancements enabling minimally invasive treatment options, improved diagnostic capabilities, and enhanced patient outcomes.

However, challenges such as limited access to dental care in certain regions, high treatment costs, and the stigma associated with dental procedures may hinder market growth.

Market Trends

Key trends observed in the periodontal treatment market include:

Adoption of digital dentistry technologies, including intraoral scanners, 3D printing, and computer-assisted implant placement, to enhance treatment accuracy, efficiency, and patient comfort.
Integration of regenerative therapies, such as growth factors, platelet-rich plasma (PRP), and tissue engineering techniques, to promote tissue regeneration and improve treatment outcomes in periodontal surgery.
Emphasis on personalized treatment approaches, incorporating patient-specific factors such as genetic predisposition, systemic health conditions, and lifestyle habits into treatment planning and decision-making.

Competitive Landscape

The periodontal treatment market is characterized by the presence of established players such as Amyndas Pharmaceuticals, 3M, Dentsply Sirona, Medtronic, and Pfizer, among others. These companies are focused on research and development, product innovation, strategic partnerships, and geographical expansion to maintain their competitive edge in the market.

Buy Full Report Here: https://www.transparencymarketresearch.com/checkout.php?rep_id=85283<ype=S&utm_source=OpenPR_Sandeep&utm_medium=OpenPR

Top Market Research Reports:

Surgical Navigation Systems Market: https://www.globenewswire.com/en/news-release/2022/07/11/2477289/0/en/Surgical-Navigation-Systems-Market-is-Predicted-to-Expand-at-a-CAGR-of-6-3-during-the-Forecast-Period-notes-TMR-Study.html

Edge Computing Market: https://www.globenewswire.com/en/news-release/2022/07/08/2476656/0/en/Edge-Computing-Market-Bolsters-with-Rise-in-Demand-for-Connected-and-Autonomous-Vehicles-Says-TMR-Study.html

State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

This release was published on openPR.